High relaxivity gadolinium hydroxypyridonate-viral capsid conjugates: nanosized MRI contrast agents.
about
Lanthanide probes for bioresponsive imagingDefinite coordination arrangement of organometallic palladium complexes accumulated on the designed interior surface of apo-ferritinVirus-Based Nanoparticles as Versatile NanomachinesDesign of ProCAs (protein-based Gd(3+) MRI contrast agents) with high dose efficiency and capability for molecular imaging of cancer biomarkersDesign of a novel class of protein-based magnetic resonance imaging contrast agents for the molecular imaging of cancer biomarkersNew clathrin-based nanoplatforms for magnetic resonance imagingVirus-based nanomaterials as positron emission tomography and magnetic resonance contrast agents: from technology development to translational medicineCell-permeable MR contrast agents with increased intracellular retentionEngineering of Brome mosaic virus for biomedical applicationsAryl-phosphonate lanthanide complexes and their fluorinated derivatives: investigation of their unusual relaxometric behavior and potential application as dual frequency 1H/19F MRI probes.Manganese(III) porphyrins complexed with P22 virus-like particles as T1-enhanced contrast agents for magnetic resonance imaging.Gd(DOTAlaP): exploring the boundaries of fast water exchange in gadolinium-based magnetic resonance imaging contrast agentsUse of YbIII-centered near-infrared (NIR) luminescence to determine the hydration state of a 3,2-HOPO-based MRI contrast agentHigh-relaxivity gadolinium-modified high-density lipoproteins as magnetic resonance imaging contrast agentsGd-hydroxypyridinone (HOPO)-based high-relaxivity magnetic resonance imaging (MRI) contrast agents.Bioresponsive, cell-penetrating, and multimeric MR contrast agents.Supramolecular protein cage composite MR contrast agents with extremely efficient relaxivity properties.Gd(III)-nanodiamond conjugates for MRI contrast enhancement.Functional viral metagenomics and the next generation of molecular toolsChallenges for Molecular Neuroimaging with MRI.Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.Genome-free viral capsids as multivalent carriers for taxol delivery.Analytical methods for characterizing magnetic resonance probes.P22 viral capsids as nanocomposite high-relaxivity MRI contrast agentsA hexanuclear gadolinium-organic octahedron as a sensitive MRI contrast agent for selectively imaging glucosamine in aqueous media.Synthesis and characterization of new porphyrazine-Gd(III) conjugates as multimodal MR contrast agentsProtein cage nanoparticles bearing the LyP-1 peptide for enhanced imaging of macrophage-rich vascular lesions.A modular system for the synthesis of multiplexed magnetic resonance probes.Modular polymer-caged nanobins as a theranostic platform with enhanced magnetic resonance relaxivity and pH-responsive drug release.Synthesis and characterization of a porphyrazine-Gd(III) MRI contrast agent and in vivo imaging of a breast cancer xenograft model.The art of engineering viral nanoparticles.Applications of orthogonal "click" chemistries in the synthesis of functional soft materials.Multivalent, high-relaxivity MRI contrast agents using rigid cysteine-reactive gadolinium complexesApplications of viral nanoparticles in medicine.Strategies for the preparation of bifunctional gadolinium(III) chelators.N-Terminal labeling of filamentous phage to create cancer marker imaging agents.Design and characterization of lisinopril-loaded superparamagnetic nanoparticles as a new contrast agent for in vitro, in vivo MRI imaging, diagnose the tumors and drug delivery system.A Simple RNA-DNA Scaffold Templates the Assembly of Monofunctional Virus-Like ParticlesFormylbenzene diazonium hexafluorophosphate reagent for tyrosine-selective modification of proteins and the introduction of a bioorthogonal aldehyde.Conjugation to Biocompatible Dendrimers Increases Lanthanide T2 Relaxivity of Hydroxypyridinone (HOPO) Complexes for Magnetic Resonance Imaging (MRI)
P2860
Q27000361-70AF9206-3755-4935-8511-21D401D38BB8Q27664130-177B7EC0-1A14-4FC7-BCBD-C30609E5F16AQ28068538-75C23C9C-53CD-4425-9752-9909C84CDA85Q28235682-F8AE4EA7-6D30-41FF-9C18-7D275BFF7035Q28283802-1623789E-10C6-4333-8678-3584C212CFC2Q28483110-C8FC0681-7D18-47B4-8B2D-580C6E6717BCQ28550482-CAD11006-4B18-4143-A03C-67E1B1628803Q28755262-06050967-454C-43DF-9631-62D25B87EFD0Q28818683-B2740DD9-F935-4797-8DAE-D64D813FE410Q30656068-E175A2F9-84CA-409B-9A2D-CC1D65D6658CQ30722696-7AA36C37-13C2-4083-A766-4F60B6A67312Q30830645-C124C85C-A411-46B5-8E5C-940ADA66C688Q33363624-999AB1DE-FE06-4DC6-9A90-75FA21E3E489Q33429230-423EFA7C-A45E-47C1-8991-95A8F12F31ADQ33463644-1D716653-C4E7-4F51-976F-8DF27EA51213Q33470566-A781CEEB-D8E0-419C-807A-90070DBFA1BBQ33514896-1F629D44-F476-4B42-AFE6-60B1F998E272Q33520972-0F86B315-0040-4B5B-BBDE-A6B24CFEACA5Q33637263-A891CF94-2273-4F76-987D-535CEF730EA7Q33680025-D8C2E1F7-CEE0-47B6-9A1B-3C6553751297Q33847006-576844C4-E718-4D87-8259-D7620D62DA22Q34057731-EEBABA38-15E4-4B45-884F-4F8A9D68265AQ34280357-F5D83664-606A-47E8-8753-3F36F8203EFFQ34289410-9704C7CE-E8B6-4B7D-955C-213AFD40A190Q34371958-1ED6D16C-FF8F-48D0-B22B-7B595D374AE4Q34785712-FFCA6541-06E6-4888-B12B-452C8E11D783Q34861181-777B51EB-D317-4BA9-87EA-E82C04F70E31Q34913014-6C42465F-928A-4D1E-B1ED-8427A839DE27Q34988879-7DB69BE9-64E9-4B78-9C99-0BB00CFBFBE4Q35082611-95C75BE4-EF0F-409C-93F8-33F4C6F62AE7Q35165714-29150CA6-FD37-4F8C-9D1B-58F43E0A4277Q35190403-06A4843D-B036-4607-90C0-02F39D890240Q35281165-5BDDAE1C-465E-4908-A0E5-0EFDC122BB79Q35501007-12284C3A-7504-4E1B-8DCA-6FD84ED98504Q35777941-422A1D3A-C236-4850-9B23-D5D8A05E94C9Q36213754-5B955C4B-8721-4725-899B-D166E289B044Q36369919-9D2D02B7-5A3B-49D5-9E1F-55E2CF88C01BQ36412662-30F42646-550A-4D70-877C-6692286567A6Q36478887-D1F04077-0DE2-40E2-8115-2A5DAAC378D4Q36714422-B6F6D20E-589F-4870-BABC-6A1611173508
P2860
High relaxivity gadolinium hydroxypyridonate-viral capsid conjugates: nanosized MRI contrast agents.
description
2008 nî lūn-bûn
@nan
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
High relaxivity gadolinium hyd ...... nanosized MRI contrast agents.
@ast
High relaxivity gadolinium hyd ...... nanosized MRI contrast agents.
@en
type
label
High relaxivity gadolinium hyd ...... nanosized MRI contrast agents.
@ast
High relaxivity gadolinium hyd ...... nanosized MRI contrast agents.
@en
prefLabel
High relaxivity gadolinium hyd ...... nanosized MRI contrast agents.
@ast
High relaxivity gadolinium hyd ...... nanosized MRI contrast agents.
@en
P2093
P50
P356
P1476
High relaxivity gadolinium hyd ...... nanosized MRI contrast agents
@en
P2093
Ankona Datta
Kenneth N Raymond
Matthew B Francis
P304
P356
10.1021/JA0765363
P407
P577
2008-02-05T00:00:00Z